Foreigners take command of German non-performance

Lone Star has been at the forefront of buying non-performing loans from German banks. Now, following the Texan private equity group’s lead, more investors are wading through the morass of Germany’s bad loans. Is this the beginning of a revolution for Germany’s banks and corporates? By Rachel Wolcott

risk-1204-pg60bruno-gif

In September, Hypo Real Estate Bank (HRE) sold e3.6 billion in real estate-related loans to Texas-based Lone Star, one of the world’s most prolific buyers of distressed assets. This deal was touted as the largest of its kind and contained e2.48 billion of non-performing loans (NPLs), the balance being sub-performing or on a watch list.

Despite the emergence of a deal of this size – which was quickly followed by another e394 million portfolio sold by HRE to Citigroup and Morgan Stanley, and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here